In his laboratory on the second floor of the new Biomedical Partnership Center on NC State’s Centennial Campus, Ke Cheng peers into a microscope, examining a dish of stem cells that may hold the key to repairing damaged cardiac tissue. The view is dramatic, not because the cells are doing anything unusual but because Cheng’s work gives us a glimpse of the future of medicine.
Since arriving at NC State in 2013 to join an interdisciplinary faculty cluster focused on regenerative medicine, Cheng has conducted groundbreaking research on the use of stem cells to treat cardiac and pulmonary diseases. He led a team that developed a synthetic version of a cardiac stem cell that may reduce the risks associated with using natural stem cells. He has also spearheaded research to improve the effectiveness and efficiency of treatment with adult stem cells.
One project focused on solving two problems associated with cell therapy: how to keep cardiac stem cells in place and how to prevent rejection when the stem cells are not from the patient’s own body. The solution involved encapsulating cardiac stem cells in a polymer gel that shields them when they’re injected into the patient’s body.
In another project, he demonstrated a simple, rapid way to generate large numbers of lung stem cells for use in treatment. Instead of attempting to isolate and sort individual lung stem cells or genetically convert other types of cells into lung stem cells, Cheng used a multicellular spheroid method to enrich and grow them.
“There are two things that put us on top: innovation and teamwork.”
“Our strengths are in veterinary medicine, engineering and the collaborations we have throughout the Research Triangle area,” says Cheng, associate director of the Comparative Medicine Institute, with appointments in the Department of Molecular Biomedical Sciences at NC State’s College of Veterinary Medicine and in the Joint Department of Biomedical Engineering, jointly administered by NC State and the University of North Carolina at Chapel Hill. “We are individually strong but jointly stronger.”
A heart for research
Kevin Huang, a second-year Ph.D. student in comparative biomedical sciences, is working on a cardiac stem cell project in Cheng’s lab. Both of Huang’s grandfathers died of heart disease in 2010, triggering his decision to pursue a career in medicine.
Huang has thrived in the graduate program, embracing the immersive —and challenging — educational experience. “In China, a teacher teaches and students learn and take a test. Here we are instructed by mentors,” he says. “Here, we learn by reading, searching, writing, making presentations and watching other students’ presentations. We get ideas from all over, and we brainstorm.”
Another student in Cheng’s lab, fourth-year Ph.D. student Uyen Dinh, is studying stem cell therapies for lung diseases. She says being on the leading edge of the field is both exciting and challenging.
“The lung group is quite new for the lab, so a lot of the things we’ve been doing are novel, and there are not many people I can ask for help,” she says. “But it’s great because it means that whatever I’m doing is going to be the first, and it’s going to have a big impact.”
Impact is at the forefront of Cheng’s mind as looks out his office window at the rows of buildings housing the veterinary teaching hospital, where colleagues are conducting research in areas that often advance both animal and human medicine, from cancer and spinal-cord injuries to prosthetics and pain management.
“There are two things that put us on top: innovation and teamwork,” he says. “Together we are doing something extraordinary.”